Financials
- Market Capitalization 599.83 M
- Employee 1 315
- Founded 2011
- CEO Ming Hsieh
- Website www.fulgentgenetics.com
- Headquarter Delaware, United States
- FIGI BBG00DR7LTG2
- Industry 診断・研究
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-13.36
売上高対価格比率
2.51
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2368 | CSTL Castle Biosciences, Inc. - Common stock | 33.64 USD | -2.27% | -6.09% | +4.15% | +36.66% | 1.03 B USD | ||
| 2374 | OPK Opko Health, Inc. - Common Stock | 1.38 USD | 0.00% | -11.54% | -13.21% | -9.80% | 1.03 B USD | ||
| 2798 | ACRS Aclaris Therapeutics, Inc. - Common Stock | 3.75 USD | -2.09% | -10.50% | -29.25% | +96.34% | 552.00 M USD | ||
| 2989 | MYGN Myriad Genetics, Inc. - Common Stock | 4.29 USD | -0.46% | -4.88% | +25.44% | -48.13% | 410.34 M USD |